Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience

被引:42
作者
Gragnano, Felice [1 ]
Natale, Francesco [1 ]
Concilio, Claudia [1 ]
Fimiani, Fabio [1 ]
Cesaro, Arturo [1 ]
Sperlongano, Simona [1 ]
Crisci, Mario [1 ]
Limongelli, Giuseppe [1 ]
Calabro, Raffaele [1 ]
Russo, Mariagiovanna [1 ]
Golia, Enrica [1 ]
Calabro, Paolo [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, Div Cardiol, Dept Cardiothorac & Resp Sci, AO Colli Monaldi Hosp, Naples, Italy
关键词
EVOLOCUMAB;
D O I
10.2459/JCM.0000000000000611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:75 / 77
页数:3
相关论文
共 12 条
[1]   Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes [J].
Bansilal, Sameer ;
Maria Castellano, Jose ;
Garrido, Ester ;
Wei, Henry G. ;
Freeman, Allison ;
Spettell, Claire ;
Garcia-Alonso, Fernando ;
Lizano, Irene ;
Arnold, Renee J. G. ;
Rajda, Jay ;
Steinberg, Gregory ;
Fuster, Valentin .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (08) :789-801
[2]   Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries [J].
Colantonio, Lisandro D. ;
Huang, Lei ;
Monda, Keri L. ;
Bittner, Vera ;
Serban, Maria-Corina ;
Taylor, Benjamin ;
Brown, Todd M. ;
Glasser, Stephen P. ;
Muntner, Paul ;
Rosenson, Robert S. .
JAMA CARDIOLOGY, 2017, 2 (08) :890-895
[3]   Automated Outreach to Increase Primary Adherence to Cholesterol-Lowering Medications [J].
Derose, Stephen F. ;
Green, Kelley ;
Marrett, Elizabeth ;
Tunceli, Kaan ;
Cheetham, T. Craig ;
Chiu, Vicki Y. ;
Harrison, Teresa N. ;
Reynolds, Kristi ;
Vansomphone, Southida S. ;
Scott, Ronald D. .
JAMA INTERNAL MEDICINE, 2013, 173 (01) :38-43
[4]   Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice [J].
Fairman, Kathleen A. ;
Davis, Lindsay E. ;
Sclar, David A. .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 :957-965
[5]   Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with: treatment duration of 1 to 2 years [J].
Farnier, Michel ;
Colhoun, Helen M. ;
Sasiela, William J. ;
Edelberg, Jay M. ;
Asset, Gaelle ;
Robinson, Jennifer G. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (04) :986-997
[6]   Cognitive Function in a Randomized Trial of Evolocumab [J].
Giugliano, Robert P. ;
Mach, Francois ;
Zavitz, Kenton ;
Kurtz, Christopher ;
Im, Kyungah ;
Kanevsky, Estella ;
Schneider, Jingjing ;
Wang, Huei ;
Keech, Anthony ;
Pedersen, Terje R. ;
Sabatine, Marc S. ;
Sever, Peter S. ;
Robinson, Jennifer G. ;
Honarpour, Narimon ;
Wasserman, Scott M. ;
Ott, Brian R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) :633-643
[7]   CONCURRENT AND PREDICTIVE-VALIDITY OF A SELF-REPORTED MEASURE OF MEDICATION ADHERENCE [J].
MORISKY, DE ;
GREEN, LW ;
LEVINE, DM .
MEDICAL CARE, 1986, 24 (01) :67-74
[8]   Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients The GLAGOV Randomized Clinical Trial [J].
Nicholls, Stephen J. ;
Puri, Rishi ;
Anderson, Todd ;
Ballantyne, Christie M. ;
Cho, Leslie ;
Kastelein, John J. P. ;
Koenig, Wolfgang ;
Somaratne, Ransi ;
Kassahun, Helina ;
Yang, Jingyuan ;
Wasserman, Scott M. ;
Scott, Robert ;
Ungi, Imre ;
Podolec, Jakub ;
Ophuis, Antonius Oude ;
Cornel, Jan H. ;
Borgman, Marilyn ;
Brennan, Danielle M. ;
Nissen, Steven E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (22) :2373-2384
[9]   2016 European Guidelines on cardiovascular disease prevention in clinical practice [J].
Piepoli, Massimo F. ;
Hoes, Arno W. ;
Agewall, Stefan ;
Albus, Christian ;
Brotons, Carlos ;
Catapano, Alberico L. ;
Cooney, Marie-Therese ;
Corra, Ugo ;
Cosyns, Bernard ;
Deaton, Christi ;
Graham, Ian ;
Hall, Michael Stephen ;
Hobbs, F. D. Richard ;
Lochen, Maja-Lisa ;
Loellgen, Herbert ;
Marques-Vidal, Pedro ;
Perk, Joep ;
Prescott, Eva ;
Redon, Josep ;
Richter, Dimitrios J. ;
Sattar, Naveed ;
Smulders, Yvo ;
Tiberi, Monica ;
van der Worp, H. Bart ;
van Dis, Ineke ;
Verschuren, W. M. Monique .
EUROPEAN HEART JOURNAL, 2016, 37 (29) :2315-+
[10]   Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial [J].
Sabatine, Marc S. ;
Leiter, Lawrence A. ;
Wiviott, Stephen D. ;
Giugliano, Robert P. ;
Deedwania, Prakash ;
De Ferrari, Gaetano M. ;
Murphy, Sabina A. ;
Kuder, Julia F. ;
Gouni-Berthold, Ioanna ;
Lewis, Basil S. ;
Handelsman, Yehuda ;
Pineda, Armando Lira ;
Honarpour, Narimon ;
Keech, Anthony C. ;
Sever, Peter S. ;
Pedersen, Terje R. .
LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (12) :941-950